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Summary
To study the association of autoimmunity and human B cell neoplasia, we have established a
model of a B cell lymphoma which expresses a pathogenic autoantibody of defined specificity .
The Ig V gene expressed in this neoplasm was analyzed longitudinally using clinical specimens
taken from the splenic lymphoma (S) at diagnosis and from lymph node relapses 3 and 4 yr
later (N3 and N4) . Southern analysis and oligonucleotide hybridization experiments demonstrated
that clonally related predominant and minor tumor cell populations were present in S at diagnosis,
and that the minor population became the predominant population in the relapse specimens,
N3 and N4 . Although the Ig specificity and idiotype were the same at diagnosis and at both
relapses, analysis of the expressed V gene sequences showed 14 base changes between S and
N3, and 2 further changes at N4 . Little sequence heterogeneity was observed at each sampling
time, indicating that the ongoing mutation frequency was low. The relevant germline precursor
V gene was determined from autologous germlineDNA and compared to the expressed genes.
Based on the pattern of shared and unshared mutations, we were able to establish the genealogic
relationship of the germline V gene and the expressed clonotypes of S, N3 and N4 . Taken
together, the findings from Southern blotting, oligonucleotide hybridization, and sequence analysis
permit us to describe a molecular aspect of tumor progression, "clonotypec shift", wherein
subpopulations of the malignant clone, marked by different V gene clonotypes, emerge and
predominate at different time points in the evolution of the lymphoma. Furthermore, the sequential
and nonrandom pattern of the V mutations, correlated with the observed conservation of
autospecificity and idiotype, implies that clonal selection may have influenced the pathogenesis
of the lymphoma .
utoimmune phenomena can occur in association with sev-
iA eral human clonal B cell disorders, such as idiopathic
cold agglutinin disease (1), chronic lymphocytic leukemia (2),
nonHodgkin's and Hodgkin's lymphomas (3, 4), and the clonal
B cell expansions seen in HIV infection (5-7) . The reasons
for the association of autoimmunity and B cell neoplasia are
poorly understood, and it is unlikely that a single mecha-
nism will explain every example. In the normal humoral im-
mune response, antigen plays a central role in provoking clonal
expansion ofB cells ; theoretically, antigen could play an anal-
ogous role in some B cell clonal diseases . Disease states in
which autoantibodies are found in association with B cell
clonal disorders offer the opportunity to investigate the role
of antigen, specifically autoantigen, in the pathogenesis of
the clonal disease.
The Ig gene can serve as a marker in clonal analysis be-
cause unique combinations ofV and J or V, D, and J seg-
ments are formed in the preimmune repertoire and are generally
conserved within a clone thereafter. The nucleotide sequence
of the CDR3, with itsN sequences, is generated by these
rearrangements and is unique to a particular clone. These fea-
tures of the Ig gene have been exploited as analytic tools in
studies of the clonality of murine and human immune re-
sponses and lymphoid neoplasms (8-12) .
The Ig gene can also serve as a genealogic record of the
processes of genetic diversification and clonal selection in a
defined B cell clone . A nonrandom distribution of sequen-
tially occurring mutations in the variable region gene can
be interpreted as evidence of antigen driven clonal selection
(13) . This approach has been applied to studies of normal
primary and secondary immune responses in murine models
(14) . Analysis of the pattern of somatic mutations has also
been applied to murine autoimmuneresponses, and has demon-
strated parallels between normal and autoimmune responses
in the mouse (15) . In human studies of normal immune re-
sponses, lymphoid malignancy, and autoirnmune disease, how-
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(10, 16-18); its potential to reveal information about clonal
selection by a specific antigen in human disease has been ex-
ploited to only a limited degree (19-21).
Our laboratory has been interested in studying the associ-
ation of autoimmunity and B cell neoplasia at a molecular
level, and we have developed a model system in which the
mechanism of that association is well defined. The model
consists of a B cell lymphoma from a patient with autoim-
mune hemolytic anemia mediated by a monoclonal IgM cold
agglutinin with specificity for a red cell carbohydrate antigen,
Pre (22) . It is known from studies of EBV transformed cell
lines derived from the lymphoma (23), that the neoplasm
secretes the pathogenic autoantibody.
From these studies we hypothesized that this lymphoma
arose from a pre-existing, expanded, autoreactive B cell clone,
and that a member ofthis clone sustained one or more trans-
forming events, resulting in the neoplasm. In following the
patient's disease, we observed that the specificity and idio-
type of this lymphoma were conserved over a 4-yr period.
This observation suggested the additional hypothesis that
clonal selection mediated by idiotype or by autoantigen (per-
haps in an altered form), might have played a role in the evo-
lution of the neoplastic B cell clone. Based on these two hy-
potheses, we predicted that ifthe neoplasticclone in this model
system demonstrated diversity of nucleotide sequence at the
Ig locus, then the pattern of that sequence divergence would
reflect clonal expansion and the influence of antigen medi-
ated clonal selection.
To test this prediction, we have undertaken a longitudinal
molecular analysis of the Ig gene in this model system, using
EBV cell lines and several clinical specimens from this pa-
tient. Interestingly, we found genetic diversity manifest as
shifts in the predominant V clonotype during the evolu-
tion of the malignant clone. Furthermore, the pattern of
nucleotide changes in the V gene fits well with a model of
antigen mediated clonal selection favoring preservation of Ig
idiotypy and specificity.
Materials and Methods
Patient Material.
￿
This model system has been described previ-
ously (22, 23). Briefly, a patient with IgM cold agglutinin medi-
ated autoimmune hemolytic anemia was found to have a splenic
lymphoma. EBV transformed B cell lines were established from
splenic lymphocytes by limitingdilution. The karyotype of the cell
lines had the same abnormalities as the tumor, and the antigen
specificity, anti-idiotype binding, and isoelectric focussing patterns
of the IgM secreted by the cell lines were the same as in the pa-
tient's serum (23). Lymph node biopsies were obtained at relapses
of the lymphoma 3 yr after the first chemotherapy induced remis-
sion, and again 15 mo after a second remission. Sections of each
clinical specimen were stained for lightmicroscopy, and were snap-
frozen or cryopreserved at -80°C. Granulocytes were harvested
from peripheralblood by collectingthe white cell layer whichoverlies
the red cell layer after density gradient centrifugation ofbuffy coats
through Sepracell (Sepratech, Oklahoma City, UK). Differential
counts of these preparations revealed >95% granulocytes. The
specificity of the anti-erythrocyte autoantibody was determined by
hemagglutination using group O human erythrocytes with and
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without ficin treatment (24). Idiotype analysis in serum was per-
formed by an ELISA assay as described by Jefferies et al. (25).
Cell Surface Staining and Flow Cytometry. Cell surface staining
was performed by incubating cell suspensions of spleen or lymph
node with a combination of fluorescein-anti-CD20 (Coulter BI;
Coulter Electronics, Hialeah, FL) and allophycocyanin-anti-Id (25)
or allophycocyanin-anti-IgM (Fisher Biotech, Orangeburg, NY)
in staining medium on ice for 15 min and then washing 3 x with
staining medium. Stained cells (0.5-1.0 x 106) were then applied
to a dual laser/dye laser flow cytometer (FACSTARpLus; Becton
Dickinson ImmunocytometrySystems; SanJose,CA) equipped with
appropriate filters for multicolor immunofluorescence (26) . Samples
included propidium iodide (1 pgm/ml) in the medium which al-
loweddead cell exclusion. Labeling of antibody with allophycocyanin
has been described previously (27).
Southern Hybridization.
￿
Genomic DNA was isolated by stan-
dard phenol/chloroform extraction (28). 5-10 pgm of DNA was
digested with Eco RI, Hind III, Bam H1, or Xba 1, electropho-
resedthrough 0.5% agarose, and transferred to Duralon nylon mem-
brane (Stratagene, La Jolla, CA). The probes used were Jx, a
3.3-kbgenomic fragment containing four ofthe six germline heavy
chain joining segments, (29, 30), JK, a 1.8-kb genomic fragment
(31), and C, a 1.2-kb fragment containing the first two exons of
the C region (32). Probes were labeled with P32 (Amersham,
Arlington Heights, IL) by random priming using the Prime-It kit
(Stratagene). Hybridization was carried out in 7% SDS/0.5 M
NaHP04, pH 7.2, and membranes were washed with decreasing
SSC concentrations, with a final wash in 0.1% SDS/0.1 x SSC
at 65°C. Autoradiographs were exposed on XAR film (Kodak,
Rochester, NY) at -70°C for 1-3 d.
cDNA-PCR. Total RNA was extracted from homogenized
lymph node specimens with a guanidinium isothiocynate method
(33). First strand cDNA synthesis from 30 Agra of total RNA used
AMV reverse transcriptase (Life Sciences, St. Petersburg, FL) and
a C,, specific oligonucleotide primer (34) (see below). One tenth
of this product was subjected to PCR amplification using synthetic
oligonucleotide primers Leader and DJ or C at final concentra-
tionsof0.21AM, and the buffer recommended by the manufacturer
for its Amplitaq recombinant thermostable Taq DNA polymerase
(Perkin Elmer Cetus, Norwalk, CT), except that the MgCl2 con-
centration was 0.75 mM. Thirty cycles of amplification were car-
ried out in a programmable thermocycler (Coy Laboratory Prod-
ucts, Ann Arbor, MI), with soak temperatures of 94°, 55°, and
72°C for 1 min each followed by 9 min at 72°C.
Cloning.
￿
PCR products were treated with Klenow fragment
(Boehringer-Mannheim GmbH, Germany) (28), gel purified, re-
covered by electroelution, and treated with T4 polynucleotide ki-
nase (Stratagene) in the presence of10 p.M ATP. Blunt end ligation
into SMA1 cut, phosphatase treated PBS M13- (Stratagene) was
carried out with T4 DNA ligase (International Biotechnologies,
Inc., New Haven, CT) at room temperature overnight. The entire
ligation reaction was cloned in the XL1 Blue strain of E. coli
(Stratagene) by heat pulse of competent bacteria or by electro-
poration (BioRad Laboratories, Rockville, NY). Bacterial colonies
were screened by blue/white selection and the presence of insert
confirmedby restriction analysis ofalkalinelysis plasmid DNA prepa-
rations (28).
Sequencing.
￿
Double stranded plasmid DNA was sequenced in
both directions by the dideoxynucleotide termination method (35)
using the Sequenase II kit (United States Biochemical Corp., Cleve-
land, OH). Sequences were analyzed using the DNA Inspector II
(Textco, West Lebanon, NH) and the Wisconsin Analysis package
(36).The serum and tissue specimens from each time point used in the longitudinal analysis of thelymphoma are shown, along with antibody specificity
and the presence of the private idiotype . Granulocytes were prepared from peripheral blood obtained during disease remissions . The template sources
and primers used to determine the V gene sequence at each time point are indicated, as are the number of independent bacterial isolates sequenced
from each amplification-ligation-cloning procedure. The sequences from 7 independent EBV cell lines at the time of diagnosis were obtained from
unamplified cDNA and were originally reported by Silberstein, et al . (23) . Abbreviations: gDNA - genomic DNA; cDNA - complementary DNA;
ND - not done ; PCR-LC - PCR amplification-Ligation-Cloning procedure; PCR-seq - Direct sequencing ofPCR product ; cloning - cloning of
unamplified CA primer extended cDNA .
Oligonucleotide Hybridization.
￿
Four pairs of 17 mer oligonucle-
otide probes were chosen as described in the text . 10 pM of each
probe was end-labeled with P'2-ATP and hybridized at 37°C over-
night . Two pairs ofPCR amplification primers were used to am-
plify V genes from each template. TheLeader-DJ primer pair was
shownby ethidium stained gels to amplify specifically the expressed
V gene from the neoplastic clone, so amplification products of
this primer pair served as controls for the specificity of hybridiza-
tion conditions. The Leader-Fr3 primer pair amplified bands of the
appropriate size by ethidium stained gelfrom all templates, so these
amplification products served to include related germline genes in
the material to be probed with the 8 oligonucleotide probes .
GenomicDNA from each lymphoma specimen, from the patient's
granulocyteDNAdiluted 1:10 or 1:30, and from normal, unrelated
lymphocyteDNA, was subjected to 30 cycles ofPCRamplification .
These dilutions ofthe patient's granulocyteDNA showed no Leader-
DJ amplified band on ethidium stained gel, while undiluted gran-
ulocyteDNA showed a faint band, indicating a small amount of
contaminationwithDNAfrom thelymphoma . The amplification
products were denatured in 0.3MNaOH for 5 min, neutralized
with 1.2M TrispH 7.0, andthe equivalent of10% ofthe original
product was dotted under vacuum onto 8 replicateDuralon strips .
The strips were probed in parallel with the 8 oligonucleotide probes
in 6 x SSC, 40 mM NaH2PO4 , 1% SDS, and 100 pgm/ml
salmon sperm DNA (Sigma Chemical Co., St . Louis, MO) and
washed in 6 x SSC/0.1% SDS at increasing temperature for in-
creasing stringency. Autoradiographic exposures after each wash
ranged from 15 min to 2 d . For each probe individually, the final
washing temperature and duration of autoradiographic exposure
were chosen to optimize the distinction between control positives
and control negatives.
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Oligonucleotides.
￿
Oligonucleotides were synthesized by auto-
mated phosphotriester chemistry (Applied Bioscience Inc., Foster
City, CA), diluted to stock concentrations andused without fur-
ther purification . The sequences were as follows: Leader: 5' ATG-
GACTGGACCTGGAGCATC 3'; DJ: 5' GCCCAGTAGTCAT
CTCCTCT 3' ; Fr3 : 5' CGGCCGTGTCGTCAGATCTTA 3' ;C :
TCAGGAGACGAGGGGGAA 3' ; Agermline : 5' CCCACTCC-
CAGGTTC3;A-mutant : 5' CCCACTCTCAGGTTC 3' ; Bgerm-
line : 5' AGAGAAACCAGGCCA 3' ; B-mutant: 5' AGAGAAAG-
CAGGCCA 3' ; Cgemmline : 5' GTGAGACTTCACCCA 3; C-mutant:
5' GTGAGACCTCACCCA 3' ; D-germline : 5' TCCTGTGTCCT
CTCC 3' ; D-mutant : 5' TCCTGTGCCCTCTCC 3'.
Statistics.
￿
The probability model for detection of positive or
negative selection from patterns of replacement and silent muta-
tions within variable region genes is described by Shlomchik et
al . (37) . Thebinomial distribution is used to model random muta-
tion, and to calculate the probability (p value) that an observed
distribution of mutations occurred by chance . Theassumptions un-
derlying this model have been validated experimentally (37) .
Results
Serial Samples: S, N3, N4
Thematerials available for comparative studies in this pa-
tient are described in Table 1 . The lymphoma sample obtained
from the spleen at the time of diagnosis will be referred to
as `S, thesample from the first lymph node relapse3 yr after
diagnosis will be referred to as `N3; and the sample from
Table 1 . Patient
Timepoint
Material and Nucleotide
Specimen
Sequences for Longitudinal
Serology
Analysis
Idiotype Isolates Sequencing technique
Diagnosis Serum IgM anti-Pr2 +
(S) Spleen tissue IgM anti-Pr2 + 3 gDNA,PCR-LC,Leader-DJ
(EBV) EBV Cell line IgM anti-Pr2 + 7 cDNA,cloning, CIA
1 gDNA,PCR-LC,Leader-DJ
1st remission Granulocytes 4 gDNA,PCR-LC,Leader-Fr3
Year 3 Serum IgM anti-Pr2 +
(N3) Lymph node IgM anti-Pr2 + 9 cDNA,PCR-LC,Leader-DJ
1 gDNA,PCR-LC,Leader-DJ
1 cDNA,PCR-seq,Leader-DJ
Year 4 Serum IgM anti-Pr2 +
(N4) Lymph node IgM anti-Pr2 ND 8 cDNA,PCR-LC,Leader-CIA
1 gDNA,PCR-LC,Leader-DJ
3rd remission Granulocytes 1 gDNA,PCR-LC,Leader-Fr-3the second lymph node relapse 4 yr after diagnosis will be
referred to as `N4'.
Histology of Serial Samples
The histologic appearance of the lymphoma changed from
S to N3. At diagnosis, the lymphoma was composed mostly
of small, uniform cells, and by Rappaport classification (38)
was a diffuse, well differentiated lymphoma, described as plas-
macytoid. In contrast, at N3 the histologic classification was
diffuse lymphoma, of mixed cell type, with small cells and
large cleaved cells, many of which resemble histiocytes. The
N4 histology was diffuse, poorly differentiated lymphoma.
The histologic features of N3 and N4 are generally correlated
with more aggressive malignant behavior and a worse prog-
nosis (38, 39). Some studies have suggested that finding
progressive histologic changes in a lymphoid neoplasm, as
in Richter's Syndrome (17, 40, 41), may indicate the emer-
gence of new, distinct neoplastic clones, although the mo-
lecular evidence on which that proposal was based did not
include analysis of clonality by nucleotide sequencing. On
the other hand, one study of histologic change from follic-
ular lymphoma to diffuse lymphoma, in which one tumor
was examined by sequence analysis, concluded that the diffuse
lymphoma was clonally related to the follicular lymphoma (18).
Conserved Specificity and Idiotype in Serial Samples
Serology.
￿
At the times of S, N3, and N4, the patient
suffered exacerbations of autoimmunehemolytic anemia, with
a fall in hemoglobin, and elevation of the reticulocyte count.
As shown in Table 1, the serum at each time point demon-
strated a monoclonal IgM cold agglutinin with anti-Pr2
specificity. During the remissions between time points S, N3,
and N4, the serum cold agglutinin titer was several fold lower
than at diagnosis or relapse, and the hemoglobin level and
reticulocyte counts returned to normal.
Anti-Idiotype Analysis.
￿
A murine monoclonal antiidiotype
antibody identifies, by an ELISA assay, a private idiotype on
this patient's cold agglutinin. The antiidiotype antibody does
not crossreactwith other humanparaproteins including those
with similar anti-Pr2 specificity (25). As shown in Table 1,
sera obtained at the times ofN3 and N4 remain reactive with
this antiidiotype antibody. Similarly, the presence ofthe idio-
type on the S and N3 cell surfaces is demonstrated by two
color flow cytometry (Fig. 1) using allophycocyanin labelled
antiidiotype antibody and suspensions oflymphoma cells. Two-
color analysis using antiidiotype versus anti-human IgM (not
shown) revealed a direct linear correlation at both time points
between idiotype and IgM expression on the cell surface. These
observations indicate that both the antigen specificity and
the unique idiotype have been conserved through the evolu-
tion of the lymphoma.
Clonal Relatedness of Serial Samples
Genomic DNA extracted from S, the EBV transformed
1 Abbreviations used in this paper. N3, N4, lymph node relapses 3 (yr) and
4 (yr), respectively; S, splenic lymphoma.
528
Id
a
100
Clonal Selection in an Autoreactive Human B Cell Lymphoma
CD20
Figure 1 .
￿
Continued cell surface expression ofa private idiotype. Sur-
face expression ofa private idiotype (Id) on the spleen (S) and year 3 node
(N3) tissues wasdemonstratedby two color flow cytometry. Thelogfluores-
cence intensity ofantiidiotype antibodycoupled to allophycocyanin is plotted
on the vertical axis, and of monoclonal anti-human CD20 (Coulter B1,
a pan B cell marker) coupled to fluorescein on the horizontal axis. Con-
tour lines represent 5% increments in cell number. Fig. 1 a shows a single
predominant cell population which is Id* and CD20+, indicating that
the spleen specimen is composed almost entirely of idiotype bearing B
cells. Fig. 1 b shows two populations of cells. One population is Id- and
CD20-, and probably represents background T cells in the lymph node.
The second population is Id+ and CD20+, and represents recurrent lym-
phoma in the node.
cell line, N3 and N4 was digested with Eco R1, Hind III,
Bam H1, or Xba 1, electrophoresed, and transferred to nylon
membranes. The blots were hybridized with probes for the
joining region of the heavy chain, J., or the joining region
of the light chain, J,,, or the IgM constant region, C, Both
heavy chain alleles in this tumor are rearranged. In the Hind
III (Fig. 2 b) and Xba 1 (not shown) digests, the JH
hybridizing restriction fragments are of the same size in all
samples. The light chain rearrangement pattern with the J,,
probe is also the same at all time points (not shown) . How-
ever, in the Eco R1 (Fig. 2 a) and the Barn H1 (not shown)
digests, one of the bands shifts to a smaller restriction frag-
ment in N3, and the other band apparently shifts to a smaller
fragment in N4. Finally, there is a less intense, third JH
hybridizing band in the Eco R1 digested DNA ofthe S sample,
running at the same size as the 7 .2-kb band in the N3 DNA.
(Fig. 2 a, lane 3).
Because it demonstrates that the three lymphoma speci-
mens share rearranged bands, the Southern analysis provides
strong evidence that the specimens are clonally related. The
Hind III and Xba 1 digests show the same pattern at all time
points, and in the Eco R1 digest, S and N3 share the 9.7-kb
band, and N3 and N4 share the 7.2-kb band. Sequence anal-
ysis of the expressed D regions (see Fig. 3 and results below)
confirmed, on the basis of shared unique sequences, that S,
N3 and N4 are clonally related. To explain the different re-
striction patterns in the Eco R1 and Bam H1 digests, we
hypothesized that the neoplastic clone had undergone genetic
changes which gave rise to distinguishable subpopulations
within the lymphoma, as has been reported in some follic-
ular lymphomas (42) . A different subpopulation was predom-
inant at each time point, and the N3 subpopulation was de-Figure 2 .
￿
Immunoglobulin gene rearrangements in serial lymphoma
samples. Hybridization of the Jx probe with restricted DNA from the
serial lymphoma samples is shown, using Eco RI in Fig. 2 A, and Hind
III in 2 B . From left to right, the lanes contain autologous granulocyte
DNA, EBV cell lineDNA, spleenDNA, N3 DNA, and N4 DNA . Size
markers are indicated on the left, and the size of each rearranged band
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tectable by Southern analysis at diagnosis as the faint third
band visible in the Eco R1 digest of SDNA . The JH hybrid-
ization pattern observed in the Eco R1 digest in N4 may
represent another subpopulation derived from the popula-
tion most prevalent in N3 .
V  Gene Sequence Diversity in Serial Samples
Consensus K  Sequences. The materials, primers, and
techniques used to determine the nucleotide sequence of the
expressed V gene at different stages in the evolution of the
lymphoma are summarized in Table 1, and the sequences are
listed in Fig. 3 . By consensus sequence, wemean the sequence
sharing the most homology with all the sequences determined
from one time point, for example, the consensus among the
9 cDNA and 1 genomicDNA sequences determined at N3 .
Each consensus sequence was obtained from at least two sep-
arate PCR amplifications, and from 7 or more independent
bacterial isolates (see Table 1) with little variation among those
isolates (see Fig. 4) . The two major different clonotypes, S
and N3/N4, have each been sequenced independently from
two separate biologic sources-the S clonotype from the EBV
lines and directly from splenic tissue, and the nodal clono-
type from the two lymph nodes biopsied a year apart . Fi-
nally, both major clonotypes were obtained once by a method
which did not rely on the clone-specific DJ primer. There-
fore, the consensus sequences presented in Fig . 3 represent
the predominant V clonotypes present at each time point .
The V gene sequences from the S sample and from one
oftheEBV cell lines were confirmed by thePCR based method
used for all the sequences reported here, and were identical
to the previously published sequence from the EBV lines ex-
cept at the third base in codon 12, which represents a
typographical error in the published sequences (23) (p. 1635) .
S and N3 differ by 1 nucleotide in the leader (codon -1),
3 within the leader-VH intron, and 10 within the V gene.
N4 differs from S by the same 14 nucleotides, and N4 has
2 additional nucleotide changes in the V gene . When the
sequence at each time point is compared with the germline
sequence (VHIGRR, discussed below), 6 nucleotide changes
are shared in all expressed sequences, 3 are found only in S
and the EBV lines, 11 are found in N3 and N4, and two ad-
ditional changes are found inN4 only. The nucleotide changes
which would result in amino acid changes are indicated on
Fig. 3 ; there are six codons with amino acid changes, and
codon 6 has two nucleotide changes each of which would
result in an amino acid change .
is shown on the right. The position ofthe germline band for each enzyme
is indicated as G. Both the Eco RI (2 A) and Hind III (2 B) digests dem-
onstrate two rearranged heavy chain alleles. The bands representing the
rearranged Ig genes shift to smaller sizes over time in the Eco R1 digest,
but remain at the same size in all specimens in the Hind III digest. The
faint bands present in all lanes are crossing reacting bands. The 8.8-kb
band in Eco RI digested N4 DNA was diffuse in numerous repetitions
of the experiment . Fig. 2 C is a map of a rearranged human heavy chain
locus showing the positions of the restriction sites which would define
the 3' end of the JH hybridizing fragment . Boxes with diagonal hatching
represent coding regions, and boxes with vertical hatching represent the
probes. H - Hind III ; B - Bam H1 ; X - Xba 1 ; E - Eco R1.VHIGRR
Spleen
EBV line
Node 3
Node 4
L primer
Leader------------------------------------------------------>
-19 -18 -17 -16 -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5
Met Asp Trp Thr Trp Ser Ile Leu Phe Leu Val Ala Ala Ala Thr
ATG GAC TGG ACC TGG AGC ATC CTT TTC TTG GTG GCA GCA GCA ACA G
--- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -
Intron---------------------- [  Probe B . . . . ] -__ ] . . . .Probe C . . . . I . . . .Probe D . . . .]-->
VHIGRR
Spleen
EBV line
Node 3
￿
_---__-__--_---_--___--__--__--__--_G---_--_-_-----__--_C---_-------__--C_---_--__--
Node 4
￿
--_--_---__--_---__--__---_---_---_-G-_--__--___--__--_-C-_-------------C-_---------
Node 3
Node 4
VH1GRR
Spleen
EBV line
Node 3
Node 4
GTAACGGACTCCCCAGTCCCAGGGCTGAGAGAGAAACCAGGCCAGTCATGTGAGACTTCACCCACTCCTGTGTCCTCTCCACAG
------------------------------------------------------------------------------------
__--_( . . . . . .Probe A . . . . . . ]Framework 1-_--_---__--_---_---_---_-------__--__--_---_---__--__---_------_---_----_--__--__--_-
-4 -3 -2 -1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Gly Ala His Ser Gin Val Gin Leu Val Gin Ser Gly Ala Glu Val Lys Lys Pro Gly Ala Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr
VHIGRR
￿
GT GCC CAC TCC CAG GrT CAG CTG GTG CAG TCT GGA GCT GAG GTG AAG AAG CCT GGG GCC TCA GTG AAG GTC TCC TGC AAG GCT TCT GGr TAC
Spleen
EBV line
------> CDR 1----------------- > Framework 2-------------------------------------------> CDR 2----__--__--___--__--__-__--__
28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58
Thr Phe Thr Ser Tyr Gly Ile Ser Trp Val Arg Gin Ala Pro Gly Gin Gly Leu Glu Trp Met Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr
ACC TTT ACC AGC TAT GGT ATC AGC TGG GTG CGA CAG GCC CCT GGA CAA GGG CTT GAG TGG ATG GGA TGG ATC AGC GCT TAC AAT GGT AAC ACA
-__ -__ --_ --_ --_ _-_ __A . -_- -_- -__ -__ -__ -__ -__ -__ -__ -__ -_- -_- -__ -__ --_ --_ --_ --_ -T- --_ --_ _-_ G-- ---
_-- _-_ --_ --_ --_ -__ --n -_- -__ -__ --_ --_ --- --- --- _-- _-- _-- _-- _-- __- _-- _-- _-- -_- _m- -_- -_- __- r__- __-
--------------------------> Framework 3--__--__--__---_--__--__--_---_---__--__---_---__--__--_---__--__--_
59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85
Asn Tyr Ala Gin Lys Leu Gin Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr Met Glu Leu Arg Ser
VHIGRR
￿
AAC TAT GCA CAG AAG CTC CAG GGC AGA GrC ACC ATG ACC ACA GAC ACA TCC ACG AGC ACA GCC TAC ATG GAG CTG AGG AGC
Spleen
￿
--T --- --_ --_ --C -__ -__ -__ -__ ___ ___ -__ -_- -__ -__ --- --- -__ --_ --_ --G --_ --_ _-_ --- --_ _A_
EBV line
￿
--T --- --- --_ --C -__ -__ -__ --_ --_ --_ --_ --- _-_ --- --- --- --_ --_ --_ --G _-- --- _-- --- -_- -A-
Node 3
￿
--T --- _-- _-- --C _-_ ---
Node 4
￿
--T --_ --- -__ --C -__ -__ -__ -__ -__ -_-
VHIGRR
Spleen
EBV line
Node 3
Node 4
￿
-_- --- _-- --- --- --- --- ---
Fr3 primer ** *** *** *** *** *** *** *
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D Region .
￿
The D region from this lymphoma appears
most homologous to the Dlr2 sequence from Ichihara et al .
(43) asshown in Fig . 3 . There aretwo nucleotide differences
from the germline Dlr2 sequence which are common to all
the expressedD regions . One ofthese shared differences results
in a serine to glycine change in codon 107, and the other,
in codon 105, is silent . The serial samples differ at only one
nucleotide in the D region; the S sample and the EBV lines
have guanine as the third base of codon 107, while N3 and
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Figure 3.
￿
Consensus V  region sequences from serial samples. The nucleotide and predicted amino acid sequences for the putative germline V gene,
VHIGRR, the lymphoma at diagnosis (S), the EBV transformed line, and the two lymph nodes 3 and 4 yr after diagnosis (N3 and N4) are shown.
Each sequence represents the consensus_of all isolates obtained from that time point . Dashes indicate identity with the germline nucleotide sequence,
and differences from germline are indicated . The predicted amino acid sequence of the germline gene is shown, and substituted amino acids are shown
below each altered codon ; silent nucleotide changes have no amino acid indicated. The positions of the Leader (L), Framework 3 (Fr3), and a portion
of the DJ amplification primers are indicated with stars . The positions of the 17-mer oligonucleotide probes A,B,C, andD used in hybridization experi-
ments are indicated above the sequence. On the bottom line, the germlineDU sequence is shown as the possible germline counterpart of the expressed
D regions. Nucleotides lacking templates inVH1GRR, Dlr2, or J4 are shown asN sequences, and differences between the expressedD regions and
Dlr2 are indicated. One nucleotide from the 5' end and three from the 3' end of the Dlr2 gene have no apparent counterpart in the expressed genes.
The codon numbering corresponds to the previously published sequences (23) ; the framework 1 region begins with codon 1 . These sequence data
are available from EMBL/GenBank/DDBJ under the accession numbers X60503, X60504, and X60505 .
N4 have adenine. The Dlr2 sequence has cytosine at this po-
sition, but codon 107 encodes glycine in all expressed samples.
Sequence Heterogeneity at Each Time Point.
￿
To assess the
microheterogeneity of nucleotide sequence within the neo-
plastic clone at each time point, we analyzed several bacterial
isolates from each amplification-ligation-cloning procedure .
The degree of sequence variationamong the sampled isolates
reflects the ongoing frequency of nucleotide changes within
the tunnor population (19) . An analogous approach was taken
Asn Asn
-------------------------------------------------- > N sequence D region-------------------------- > N sequence
86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112
Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys Ala Arg Ala Pro Gly Tyr Cys Ser Gly Gly Ser Cys Tyr Arg Gly Asp
CTA AGA TCT GAC GAC ACG GCC Germline Dlr2 A GGA TAT TGT AGT GGT GGT AGC TGC TAC TCC
--- --- --- --- --- --- --- GTT TAT TAC TGT GCG AGA GCA CCG --- --- --- --- --G --- G-G --- --- AGA GGA GATConsemus
S
CDR 1
Leader
￿
Frwk 1
￿
1
￿
Frwk 2
￿
CDR 2
￿
Frwk 3
mutation from germline
￿
mutation from germline not
- shared by all clonotypes
￿
- shared in all clonotypes
I _ difference from consensus
- in an individual sequence
Figure 4.
￿
V region diversification and sequence microheterogeneity in
S, N3, and N samples. Each sequence is represented as a horizontal line.
The top section ofthe figure shows a comparison ofthe germline sequence
(VHIGRR) with the consensus sequences from each time point (S, N3,
and N4). Closed lollipop symbols represent differences from the germline
which are shared in all sequences. Open lollipop symbols represent differ-
ences from germline which are found only in one clonotype. Below, in-
dividual sequences from independent isolates are represented as horizontal
lines grouped by the two major clonotypes, S and N3-N4. Within each
group, only nucleotide differences from the consensus sequence at that
time are shown as vertical bars. The 7 EBV line sequences were previously
reported (23), and the S-PCR and EBV2-PCR sequences represent repeti-
tions of those sequences by the PCR based method.
in analyzing sequence heterogeneity at diagnosis (23), by com-
paring seven independent EBV transformed lines established
from the spleen sample.
Fig. 4 shows a schematic representation of the consensus
sequences (top 4 lines), of the seven individual heavy chain
sequences determined at diagnosis (23), and the additional
individual sequences at S, N3 and N4 reported here. A small
degree of sequence microheterogeneity is apparent at each
time point: 3 bases in S, 3 bases in N3, and 5 bases in N4.
Some of this sequence variation may be attributable to infidelity
of Taq polymerise, which has been reported to result in an
error rate of 1/5000 (44) to 1/9000 (45) errors per base poly-
merized. Under the assumption that the error rate from Taq
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polymerase infidelityis as high as 1 error/5000bases, the ex-
pected number of errors that would occur during 30 cycles
of amplification of a 450 base sequence is 2.7 errors per
amplification procedure. The error rate observed in our labo-
ratory may be lower; we have seen no errors in at least 5,000
bases amplified and sequenced from the expressed V genes
of EBV transformed clones from this and other patients. Fi-
nally, sequence variation was observed at diagnosis (Fig. 4,
EBV lines) by a method not dependent on Taq polymerise.
Thus, we conclude that a small degree of sequence variation
is present within each sample, and that Taq infidelity may
account for a few base differences, but does not account for
all the observed heterogeneity.
Intermediate Sequences.
￿
In addition to the small degree of
heterogeneity illustrated in Fig. 4, we found clonotypic se-
quences which appear to represent intermediate steps between
the germline and S, and between the N3 and N4 consensus
sequences; we will refer to these as intermediate sequences.
First, two sequences from genomic DNA from S (not depicted)
were identical to the S and EBV consensus sequences except
in codons 79 and 85, which were, respectively, GCC and
AGC, the same as the germline gene VHIGRR, instead of
GCG and AAC as in the S and EBV consensus sequences.
These two sequences may therefore represent an intermediate
step between the germline and the consensus S sequences.
Second, three of the eight N4 sequences (N4-3, N4-5, and
N4-10) have cytosine as the third base in codon 35 while the
remaining five N4 sequences have thymine. Since cytosine
is found at this position in N3, these three N4 sequences
may represent an intermediate step between N3 and N4. The
finding of intermediate sequences suggests that the nucleo-
tide changes occurred sequentially rather than as one event.
Determination of the Putative Germline Gene Sequence
The nucleotide sequence of the putative germline gene from
which the expressed Va gene in this tumor is derived is
shown as the top line of Fig. 3. The gene was not repre-
sented in the EMBL/Genbank databases, and we will refer
to this sequence as VHIGRR.
Approach.
￿
Previous approaches to the isolation of germ-
line precursor V a genes have involved screening genomic
libraries with a cDNA probe derived from the rearranged
gene to obtain a set ofcandidate germline genes, which were
then sequenced (46) . In our PCR based method, an analo-
gous set of candidate V genes was obtained by amplifying
germline genomic DNA with the Leader-Fr3 primer pair
(indicated on Fig. 3), which was chosen from the sequences
of the rearranged genes. This set was then sampled by se-
quencing several bacterial isolates. For both approaches, the
choice of the most likely germline precursor of the rearranged
Va gene is based on two criteria: the degree of homology
between the germline and the expressed genes, and the repeated
occurrenceof the germline gene in the set ofcandidates. The
potential advantage of the PCR based method lies in the ability
to define a more limited set ofcandidate genes by careful choice
ofamplification primers. While the assignment ofa precursor
germline gene can never be made with complete certainty,
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EBV-1
EBV-2 L - - I I- - Iseveral independent lines of argument strongly support the
assignment ofVH1GRR as the germline precursor in this
system .
Choice ofPrimers.
￿
The Leader primer was chosen because
it is specific for the V,tt family (47) and because it may have
a polymorphism near its 3' end which might further limit
its scope of amplification (our unpublished observation) . The
Fr3 primer was chosen from a portion of the V framework
3 common to all of the expressed clonotypes, but as different
as possible from other published Vt germline genes
(47-49) . We anticipated that this primer pairwould amplify
a limited set of V i genes which would be closely related
to the expressed genes ; an appropriate size product from un-
related genomicDNA as well as from autologous granulo-
cyte DNA was observed on ethidium stained gel (not shown) .
Repeated Isolation .
￿
We performed separate amplification-
ligation-cloning procedures on two specimens ofthe patient's
granulocyte DNA obtained 2 yr apart and sequenced a total
of 5 isolates from the two transformations . Repeating the
amplification-ligation-cloning procedure and forming a con-
sensus sequence among several isolates minimizes the chance
that sequence errors introduced during the amplification with
Taq polymerase or during the cloning procedure would be
interpreted as actual genomic sequence. Of the 5 isolates from
the two amplifications, three were identical and two had single
bases differences from the others, so that at those two posi-
tions, 4/5 isolates were identical and one discordant . These
two bases may represent Taq infidelity or, alternatively, there
may be two or more nearly identical copies of this germline
gene in the genome.
Homology.
￿
An unrestricted computerized search of the
GenBank/EMBL databases using the FASTA algorithm of
the Wisconsin Sequence Analysis package (36) demonstrated
that VH1GRR is more homologous to the rearranged gene
sequence than any other published gene . The homology be-
tween VH1GRR and the rearranged genes from S and N3
is 97% and94% respectively, counting only the coding regions
(including the Leader-V intron would increase the percent
homology) . The closest match in the databases was a rear-
ranged V t gene (50) with 95% homology, and the closest
Vt germline gene (51) was less than 90% homologous .
BecauseVH1GRR was isolated from the candidate set 5/5
times, and because VH1GRR has the highest homology of
any known V, t t gene to the rearranged genes of this clone,
we are confident in assigning it as the germline precursor
of the expressed rearranged genes.
Oligonucleotide Hybridization
We designed a hybridization experiment with clonotype-
specific oligonucleotide probes to seek independent support
fortwo of the important findings described above : first, that
the N3 clonotype was present in the spleen sample, and second
that VH1GRR is a germline gene . Genomic DNA from S,
the EBV line, N3, the patient's granulocytes, and unrelated
germline DNA was amplified with either the Leader-DJ or
the Leader-Fr3 primer pairs and dotted onto nylon membranes
in replicate strips. The strips were hybridized with 17-mer
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oligonucleotide probes which corresponded to regions of the
V gene where the germline and N3 sequences differed by
one base. The probes were synthesized in pairs, one germline
probe identical toVH1GRR (and to S) and one mutant probe
identical to the same region of N3 and differing from the
germline probe only at the central nucleotide. The positions
of the four oligonucleotide probe pairs, A through D, are
indicated on Fig. 3 .
The hybridization results are shown in Fig. 5 . The pres-
ence ofmutantN3 sequences in the spleenDNA was demon-
strated by probes Bmutant and Dmutant which show faint hy-
bridization to the amplified SDNA under conditions where
the EBV lineDNA is negative. These findings corroborate
the interpretation of the Southern analysis, where the Jti re-
striction pattern of Eco R1 digested SDNA (Fig . 2 a) sug-
gested that the N3 population was present as a minor popu-
lation in the spleen .
Figure 5 .
￿
Oligonucleoride hybridization experiments . The Leader-DJ
or Leader-Fr3 primer pairs were used to amplifyV genes from genomic
DNA templates from the sources shown, and replicate strips dotted with
equal amounts of each amplification product were hybridized with the
germline or mutant version of each oligonucleotide probe. For each of
4 probe pairs, the germline and mutant versions differed only at the cen-
tral nucleotide. TheEBVlineDNA, N3, and normalDNA amplified with
Leader-DJ served as the controls by which the optimal washing tempera-
tures and exposure durations to demonstrate the single base differences
were chosen . All germline probes hybridized with amplification products
which contain either germlineV genes or the expressed SV gene. All
mutant probes hybridized only with amplification products which con-
tain the expressed N3 V gene. Probes B and D demonstrate the pres-
ence of mutant N3 sequences in the spleen sample amplified with both
primer pairs, while probes A and C do not .The hybridization experiment also demonstrates that all
4 germline probes and none of the mutant probes hybridize
strongly with amplification products ofgermline DNA from
autologous granulocytes and from unrelated lymphocytes. This
finding confirms that at least the 67 bases of VH1GRR
spanned by the 4 probes are present in germline DNA .
Mechanism ofV Gene Change Between the Serial Samples
Two molecular changes at the Ig locus have been observed
between the serial samples : restriction fragment size reduc-
tions, and nucleotide changes . To investigate the possibility
ofDNA deletions that might explain the size reduction in
J ti hybridizing Eco R1 and Barn H1 restriction fragments,
the Xba 1 digested DNAs were probed with the C,n probe
(see map, Fig. 2 C) . The same size C,, hybridizing fragment
was observed in all specimens (not shown), eliminating the
possibility of deletions 3' of the J region . Deletion ofDNA
5' of the VDJ between the 5' Eco R1 site and the 5' Hind
III site remains a likely mechanism to explain the changes
on Southern blot because such a deletion could alter the re-
striction pattern in Eco RI and Bam H1 digests but not in
Hind III or Xba 1 digests, as observed . Alternatively, the
restriction fragment length changes could be due to point
mutations creating new Eco R1 and Barn H1 sites.
The mechanism of the nucleotide changes between the
germline and expressed V genes is most likely point muta-
tion . Sequential accumulation of nucleotide changes is char-
acteristic of somatic point mutation, and several observations
indicate that the nucleotide changes from the germline to
S and N3 indeed occurred sequentially. First, the existence
of intermediates between the germline and S, and between
N3 andN4 suggests a sequential process . Second, in the oli-
gonucleotide hybridization experiment, there is discordance
in the hybridization of mutant probes B and D versus probes
A and C to SDNA amplified with either leader-DJ or Leader-
Fr3 under conditions where the EBV cell lineDNA is nega-
tive with all four probes (Fig. 5) . A hybridization signal is
detectable with Bm,ttant and Dmntant, consistent with the pres-
ence of theN3 population as a minor constituent ofthe spleen
specimen, as discussed earlier. No such signal is seen in the
corresponding dots for Amatant or Cmutant " This discordance
suggests that the B andD mutations may have occurred be-
fore the splenectomy and the A and C mutations after the
splenectomy. The independent and sequential nature of the
changes observed here is most consistent with the mecha-
nism of point mutation, although the theoretic possibility
of multiple, overlapping gene conversion events (52, 53) cannot
entirely be ruled out .
Discussion
We have made serial observations ofhistology, specificity,
idiotype, V gene rearrangement, and V gene nucleotide se-
quence in ahuman B cell lymphoma associated with autoim-
mune hemolytic anemia . In addition, we have determined
the sequence of the putative germline precursor of the V, t
gene expressed by this neoplasm . Comparison of the results
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over time demonstrates conservation of Ig structure at the
serologic level, but considerable diversity among clonally
related neoplastic subpopulations at the nucleotide level. Based
on these findings, we propose a model for the genesis and
evolution of this lymphoma, expressed schematically in Fig .
6 and 7. Fig. 6 shows the early clonal expansion and intraclonal
divergence in relation to clinical events such as diagnosis, re-
lapse, and treatment . Fig. 7 shows the genealogic pattern of
nucleotide sequence divergence within the neoplastic clone.
This model incorporates two key observations from the analysis
of this case. First, genetic diversity was generated early in
the evolution of the neoplasm, and second, that the pattern
of nucleotide changes is consistent with antigen mediated
selection .
Divergent Populations Within a Single Clone
The Southern blot and sequence data demonstrate that this
lymphoma is a monoclonal B cell expansion. Within the neo-
plastic clone, we have detected two major divergent subpopu-
lations or clonotypes, S and N3, one predominant in the spleen
specimen, and one predominant in the lymph nodes but de-
tectable in the spleen . TheN4 clonotype has further diverged
from N3 . The presence of two intermediate clonotypes, be-
tween germline and S, and between N3 and N4, and the pres-
ence of sequence heterogeneity at each time point suggests
that other minor clonotypes may exist within the clone as
well . Fig. 6 shows our concept ofhow divergent clonotypes
emerged . A single ancestor gave rise to an expanded B cell
population that underwent genetic divergence, whichwe ob-
serve as the base changes shared by all clonotypes . Onemember
of this population was transformed and subsequently con-
tinued to expand and diverge, giving rise to the genetic differ-
ences between the clonotypes. Alternatively, it is possible that
the transforming event occurred before the observed genetic
divergence, and that selection acting on the neoplastic clone
is responsible for the presence ofshared mutations . Ultimately,
subpopulations with distinct clonotypes appeared as clini-
cally detectable lymphoma, first in the spleen and later in
the lymph nodes. This model of clonal divergence invokes
a single step transforming event ; however, a multistep trans-
formation process involving more than one subclone cannot
be ruled out .
In Fig. 6, the line indicating the splenectomy extends
through the top portion of the N3 clonotype, representing
the fact that N3 was detectable in the spleen specimen by
Southern analysis and oligonucleotide hybridization . This
finding along with the sequence data shows that the N3 clono-
type was not derived from the S clonotype by accumulation
of additional changes, but rather, the two clonotypes share
acommon ancestor. From this, we draw the conclusion that
the observed genetic diversity arose early in the evolution of
this clone.
In contrast, the minimal degree of sequence heterogeneity
(Fig . 4) within each sample (S, N3, N4) suggests that the
frequency of ongoing point mutation at each time pointi s
low. The degree of heterogeneity is less than that observedFigure 6.
￿
Emergence of subpopulations in relation to diagnosis, sam-
pling and histology. The proposed model for the emergence of divergent
subpopulations in an autospecific B cell lymphoma begins with an ex-
pended autoreactive B cell clone, represented as lightly stippled circles .
Malignant transformation, represented as heavy stippling, occurs in one
cell in this clone . The width of the shaded areas represents the relative
mass of a subpopulation, and horizontal lines represent specific events,
such as clinical detection at diagnosis, and sampling at splenectomy .
Diversification by somatic mutation occurs in the V region before trans-
formation and continues after transformation, and concurrently, antigen
may mediate positive and negative selection . The sequence divergence of
the major clonotypes, S and N3, occurs temporallywell before any clinical
manifestation of lymphoma or cold agglutinin disease. The relative mass
of cells with the predominant clonotype is represented as the heavily stip-
pled region, which enlarges until the tumor becomes clinically apparent,
and becomes smaller after treatment . The histologic description of each
sample is indicated . N3 becomes apparent as a relapse three years after
the presentation of S at diagnosis, but N3 does not arise directly from
S. The N4 clonotype arises from N3 because it shares all the mutations
of N3, but the divergence of N4 from N3 cannot be placed in a precise
time frame basedon the data available . Finally, the two intermediate clono-
types detected by sequencing are shown as darkly stippled circles .
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￿
Divergent clonotypes : the pattern ofV gene mutations. The
V clonotypes detected in longitudinal analysis are arranged in a genea-
logic tree based upon shared andunshared mutations, beginning with the
VH1GRR sequence as the germline. On the right, the distribution of
mutationsbetweenCDR and Framework, and between Replacement and
Silent, are shown . The numbers in circles are the total number of muta-
tions which occurred between each clonotype. Six mutations are shared
in all the clonotypes, and 4/6 result in amino acid replacements of which
3 occurred withinCDR regions. Three mutations occur in S only, which
is therefore the closest to germline of the expressed V genes. In contrast,
12 mutations different from those in S are present in the N3 and N4 . Of
these 12, 8 are silent, 3 occur in the Leader-V intron, and 1 results in
a conservative tyrosine to phenylalanine change in codon 32 ofCDRI .
Comparison ofthe expressedD regions with Dlr2 demonstrated a similar
pattern ; of the shared D region mutations, one results in an amino acid
replacement and one is silent, while the mutations unique to S or N3
are both silent .
by Cleary (19) in follicular lymphomas, and less than that
observed in secondary immune responses in mice (12) where
the rate was estimated to be 10-3 mutations perbasepair per
division . This high rate has been termed "somatic hypermu-
tation". The mutation frequency ongoing in each sample of
this malignant clone is not typical of somatic hypermuta-
tion, and thereforewouldnot account fortheobserved genetic
diversity.
In indolent B cell lymphomas such as this, remission is
easily induced by mild, nonablative chemotherapy, but the
tumor generally recurs (54) . In the case presented here, the
lymphoma had different histologic appearances at diagnosis
and recurrence, and genetic analysis demonstrated theemer-
gence of new subpopulations representing divergent clono-
types . The analysis also suggests that these clonotypes were
present early in theevolutionof theclone, and were not the
result of genetic changes accumulated during later stages of
tumor progression, as hasbeen demonstrated forchromosomal
changes in many hematopoietic malignancies (55) . Thehisto-
logic and clonotypic changes are two manifestations of het-
erogeneity within the malignant clone, but cannot be con-
nected in a simple way. Numerous factors unrelated to Ig
functionmaycontribute to the emergence of such newmalig-
1oX
Node year 3
1 CDR 5 Frwk
1 CDR
3 Intron
----------
(D j
0 1 Frwk
1 CDR
Node year 4
0= Intermediate 7 14nant subpopulations. For instance, heterogeneity of expres-
sion ofa molecule responsible for drug resistance may permit
a small subpopulation to survive chemotherapy which elimi-
nated the majority of the malignant clone (56, 57). Intraclonal
heterogeneity in mitotic rate might also result in differential
susceptibility to chemotherapy. From the data presented here,
we can draw the conclusion that the observed histologic
changes and shift in banding pattern on Southern analysis
are due to the emergence of a divergent subpopulation of
the original malignant clone rather than a second, new malig-
nant clone, as has been suggested in some studies of B cell
neoplasms (17, 40). In this diffuse lymphoma, as in one pre-
viously reported case of follicular lymphoma (18), only se-
quence analysis provided definitive evidence of clonality.
Antigen Driven Clonal Selection
We advanced the hypothesis that this lymphoma arose from
a preexisting autoreactive B cell clone which had been ex-
panded under the influence of the autoantigen, and further-
more, that the malignant clone continued to be influenced
by autoantigen after transformation. To support this
pathogenetic model, we sought evidence of antigen medi-
ated clonal selection by applying the probability analysis of
(37) to the observed pattern of nucleotide mutations in the
divergent subpopulations ofthis lymphoma. Each base differ-
ence between VH1GRR and the expressed V genes was
characterized as causing an amino acid replacement or as si-
lent, and as occurring in a CDR region or a framework re-
gion, and these results are shown in Fig. 7.
Because N4 is the most divergent clonotype, analysis of
N4 for evidence of clonal selection should reflect selective
forces acting over the entire evolution of the clone. Although
the fraction of replacement mutations expected at random
is about 0.75 (58), N4 contains more silent than replacement
mutations. When the probability model is applied to the pat-
tern of mutations in N4, the null hypothesis, that the distri-
bution of mutations in N4 occurred by chance, is rejected
with a confidence ofp < 0.003. There are significantly fewer
replacement mutations than would be expected at random.
This result suggests that clonal selection against replacement
mutations, or "negative selection'; has influenced the pat-
tern of divergence in this neoplastic clone. By "negative se-
lection" we mean selection against mutations which would
disrupt Ig structure, reduce affinity for antigen, or result in
loss of specificity or idiotype. The pattern of mutations in
N4 suggests that clonal selection against replacement muta-
tions is a plausible explanation for the observed conservation
of specificity and idiotype in this neoplasm.
In principle, both positive and negative selection may occur
during the evolution of an immune response, both con-
tributing to the development of high affinity and narrow
specificity. "Positive selection", selection in favor of muta-
tions which might increase affinity for antigen, can be in-
ferred when there is an excess of replacement mutations in
CDR regions. Of the shared mutations which occurred in
the early expansion of the clone, 4/6 are replacement muta-
tions of which 3/6 occur within CDR regions. Only six
mutationalevents occurred in the early phase, too few to pro-
vide statistical evidence for positive selection. The distribu-
tion of replacement mutations in the early phase, however,
differs markedly from the pattern in N3 and N4, where si-
lent mutations predominate. The change in the pattern of
mutation suggests that positive selection may have influenced
the early phase of this immune response, whilethe laterphase
was dominated by negative selection. The concept of posi-
tive selection followed by negative selection, which has also
been proposed in models of murine antihapten responses (11,
59), is consistent with our hypothesis that this autoreactive
clone was preferentially expanded before neoplastic transfor-
mation.
Our previous work with this model system defined a mech-
anismwhich explains the association ofan autoantibody medi-
ated human disease with a B cell clonal disorder. The current
findings from longitudinal analysis of V gene changes in
this system demonstrate a pathologic feature of B cell neo-
plasia, clonotypic shift. Shifts in the predominant V clono-
type coincided with recurrences of the lymphoma over a 4-yr
period. Clonotypic shift may be a molecular correlate of the
emergence of a subpopulation which has other variant char-
acteristics, for example, a different histologic appearance or
increased drug resistance. Clonotypic shift differs from the
conventional view of tumor progression, because diversity
ofclonotypes is generated early in the clonal evolution, whereas
the commonly observed genetic changes, such as chromosomal
abnormalities, are thought to accumulate during the later
stages of the disease.
The findings from this longitudinal analysis also substan-
tiate our hypothesis that autoantigen played a role in the patho-
genesis of this autoreactive B cell clone. Analysis of the rele-
vant germline and expressed V sequences allowed us to
construct a genealogic tree representing evolutionary changes
in the B cell clone. The pattern of nucleotide substitutions
suggested, first, that the clone may have been preferentially
expanded prior to transformation and second, that the clone
established and maintained idiotypy and specificity, at least
in part, by a process of clonal selection mediated by au-
toantigen.
This enlarged model for the association of autoimmunity
with B cell clonal disorders would predict that autoreactive
clones might in general be expanded relative to clones with
other specificities, providing larger "targets" for stochastic
transforming events.
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